Neumann Claas Lennart, Schulz Egbert Godehard
1 BRAVE e.V., Göttingen.
Ther Umsch. 2015 Sep;72(9):587-91. doi: 10.1024/0040-5930/a000723.
Despite a large number of existing telemedical applications as well as numerous issues in the current implementations, the desire for intensified integration of IT solutions for the health sector is unanimous amongst all actors involved (patients, practitioners, software and hardware developers, insurers, services, etc.). This reflects the state of digital systems in use in medicine today which have yet to arrive in the 21st century and operate well below the technologically possible. Telemedica/ methods remain mainly associated to flagship projects with often limited mid- or long termimpact on patient care practicesror scientific research. Supraregional or national standards are far from being defined. The register EUSTAR under patronage of the ESH is designed to fill gaps in the current IT solutions by utilization of the innovative software system SCITIM 0 to enable broad application of telemedicine and thereby provide evidence for its scientific and economical feasibility. For this the utilization of interventional decentralised telemonitoring (idTM 0 } is suitable as it preserves clear and direct patient practitioner bonds and communication. The fundamental measure of idTM 0 - to judge the quality of the te/emedica/ application by the medical quality of the consequent actions -is rarely considered by the majority of smaller projects where other tetemedical applications and methods are established.
尽管现有大量远程医疗应用程序以及当前实施过程中存在诸多问题，但所有相关方（患者、从业者、软硬件开发者、保险公司、服务机构等）都一致希望加强医疗领域信息技术解决方案的整合。这反映了当今医学中使用的数字系统的现状，这些系统尚未进入21世纪，其运行水平远低于技术上可行的水平。远程医疗方法主要仍与旗舰项目相关，对患者护理实践或科学研究的中长期影响往往有限。超区域或国家标准远未确定。在欧洲抗风湿病联盟（ESH）赞助下的EUSTAR登记册旨在通过利用创新软件系统SCITIM 0来填补当前信息技术解决方案的空白，以实现远程医疗的广泛应用，从而为其科学和经济可行性提供证据。为此，采用介入式分散远程监测（idTM 0）是合适的，因为它保持了清晰直接的医患联系和沟通。idTM 0的基本措施——根据后续行动的医疗质量来判断远程医疗应用的质量——在大多数建立其他远程医疗应用和方法的较小项目中很少被考虑。
